Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial

Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial

Viktor V Chirikov,1 Chris Walker,2 Jennifer M Stephens,1 Patricia Schepman,3 Richard Chambers,4 Mahmoud Bakir,5 Gregory W Poorman,1 Seema Haider,6 Mohammed Farghaly7 1OPEN Health, Bethesda, MD, USA; 2Global Medical Affairs, Viatris, Tadworth, UK; 3Global Health Economics and Outcomes Research, Pfize...

Full description

Bibliographic Details
Main Authors: Chirikov VV, Walker C, Stephens JM, Schepman P, Chambers R, Bakir M, Poorman GW, Haider S, Farghaly M
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
markov
nsaids
comparative effectiveness
safety
gulf region
afme
mena
Online Access:https://www.dovepress.com/evaluating-the-cost-effectiveness-of-celecoxib-versus-ibuprofen-and-na-peer-reviewed-fulltext-article-CEOR

Internet

https://www.dovepress.com/evaluating-the-cost-effectiveness-of-celecoxib-versus-ibuprofen-and-na-peer-reviewed-fulltext-article-CEOR

Similar Items